Why is Pharmaids Pharma falling/rising?

As of 22-Aug, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 62.00, reflecting a decrease of 1.0 or 1.59%. The stock has underperformed its sector today by 1.93%, and its delivery volume has significantly dropped by 23.9% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has decreased by 0.64%, and it has shown a substantial decline of 12.03% year-to-date, despite a strong performance of 40.94% over the past year. However, the company is facing challenges, including operating losses and a weak long-term fundamental strength, as evidenced by a negative EBITDA and a high debt-to-EBITDA ratio.
In the broader market context, the Sensex has increased by 0.88% over the past week, contrasting with Pharmaids' recent performance. While the stock has outperformed the broader market over the last year, the recent negative trends in operating profit and a significant drop in delivery volume suggest that investor sentiment is deteriorating. The company's poor long-term growth prospects, highlighted by an annual decline in operating profit and a low ability to service debt, contribute to the stock's current downward movement.